These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20049513)

  • 1. Protease inhibitor SERPINA1 expression in epithelial ovarian cancer.
    Normandin K; Péant B; Le Page C; de Ladurantaye M; Ouellet V; Tonin PN; Provencher DM; Mes-Masson AM
    Clin Exp Metastasis; 2010; 27(1):55-69. PubMed ID: 20049513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
    Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.
    Ouellet V; Ling TH; Normandin K; Madore J; Lussier C; Barrès V; Bachvarov D; Rancourt C; Tonin PN; Provencher DM; Mes-Masson AM
    BMC Cancer; 2008 Nov; 8():346. PubMed ID: 19032793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma.
    Farshchian M; Kivisaari A; Ala-Aho R; Riihilä P; Kallajoki M; Grénman R; Peltonen J; Pihlajaniemi T; Heljasvaara R; Kähäri VM
    Am J Pathol; 2011 Sep; 179(3):1110-9. PubMed ID: 21723846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).
    Zietarska M; Maugard CM; Filali-Mouhim A; Alam-Fahmy M; Tonin PN; Provencher DM; Mes-Masson AM
    Mol Carcinog; 2007 Oct; 46(10):872-85. PubMed ID: 17455221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
    Bonome T; Lee JY; Park DC; Radonovich M; Pise-Masison C; Brady J; Gardner GJ; Hao K; Wong WH; Barrett JC; Lu KH; Sood AK; Gershenson DM; Mok SC; Birrer MJ
    Cancer Res; 2005 Nov; 65(22):10602-12. PubMed ID: 16288054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer.
    Kwon CH; Park HJ; Choi JH; Lee JR; Kim HK; Jo HJ; Kim HS; Oh N; Song GA; Park DY
    Oncotarget; 2015 Aug; 6(24):20312-26. PubMed ID: 26015410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
    Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
    Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
    Manderson EN; Mes-Masson AM; Novak J; Lee PD; Provencher D; Hudson TJ; Tonin PN
    Genome Res; 2002 Jan; 12(1):112-21. PubMed ID: 11779836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features.
    Abd El-Wahed MM
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):173-83. PubMed ID: 16799655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of three new serous epithelial ovarian cancer cell lines.
    Ouellet V; Zietarska M; Portelance L; Lafontaine J; Madore J; Puiffe ML; Arcand SL; Shen Z; Hébert J; Tonin PN; Provencher DM; Mes-Masson AM
    BMC Cancer; 2008 May; 8():152. PubMed ID: 18507860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.
    Cody NA; Zietarska M; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    BMC Med Genomics; 2008 Aug; 1():34. PubMed ID: 18687136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
    Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
    Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
    Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.
    Popadiuk CM; Xiong J; Wells MG; Andrews PG; Dankwa K; Hirasawa K; Lake BB; Kao KR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2216-23. PubMed ID: 16609037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
    Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
    Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
    Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.
    Samouëlian V; Maugard CM; Jolicoeur M; Bertrand R; Arcand SL; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):497-504. PubMed ID: 15258697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.
    Jones MB; Michener CM; Blanchette JO; Kuznetsov VA; Raffeld M; Serrero G; Emmert-Buck MR; Petricoin EF; Krizman DB; Liotta LA; Kohn EC
    Clin Cancer Res; 2003 Jan; 9(1):44-51. PubMed ID: 12538450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.